1. Harnessing host immune responses to preneoplasia: promise and challenges

   • Madhav V. Dhodapkar

   Opinion Paper 16 December 2004 Pages: 409 - 413

2. Immunotherapy for superficial bladder cancer

   • Ellen A. M. Schenk-Braat
   • Chris H. Bangma

   Review 23 November 2004 Pages: 414 - 423

3. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn

   • Ella Kagan
   • Govind Ragupathi
   • Philip O. Livingston

   Original Article 30 December 2004 Pages: 424 - 430

   

4. Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy

   • Sonja Offner
   • Armin Hekele
   • Birgit Kohleisen

   Original Article 16 October 2004 Pages: 431 - 445

   

5. Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-β

   • Zheng-Cai Jia
   • Li-Yun Zou
   • Yu-Zhang Wu

   Original Article 16 November 2004 Pages: 446 - 452

   

6. A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

   • Ralf G. Meyer
   • Cedrik M. Britten
   • Thomas Wölfel

   Original Article 31 December 2004 Pages: 453 - 467

   

7. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production

   • Makoto Kubo
   • Takashi Morisaki
   • Mitsuo Katano

   Original Article 09 December 2004 Pages: 468 - 476

   

8. Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

   • Mary E. Dominiecki
   • Gregory L. Beatty
   • Yvonne Paterson

   Original Article 06 October 2004 Pages: 477 - 488

   

9. Induction of specific human primary immune responses to a Semliki Forest virus–based tumor vaccine in a Trimera mouse model

   • Bing Ni
   • Wenda Gao
   • Yuzhang Wu

   Original Article 27 January 2005 Pages: 489 - 498

   

10. Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis

    • Alan D. Brooks
    • Thomas J. Sayers

    Short Communication 22 December 2004 Pages: 499 - 505

    

11. In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment

    • Philipp Schütt
    • Ulrike Buttkereit
    • Thomas Moritz

    Short Communication 20 November 2004 Pages: 506 - 512